NEWS
By Ruth R. Faden | February 12, 2010
Much has been written and discussed recently about Henrietta Lacks, the African-American woman from Baltimore whose cancer cells, collected for research 60 years ago -- as she was being treated for the cervical cancer that took her life --inexplicably but astoundingly grew in the laboratory without end. The cells, named HeLa, have contributed to cancer therapies, the polio vaccine and a myriad of other biomedical advances. Sadly, in 1951, tissue from patients destined exclusively for biomedical research -- and not, for example, to diagnose or treat disease -- was commonly taken without their consent, stored and used by scientists.
HEALTH
By Meredith Cohn, The Baltimore Sun | August 24, 2010
Doctors and researchers involved in embryonic-stem-cell experiments in Maryland and nationwide fear that potentially life-saving discoveries are being jeopardized by a judge who has blocked federal funding for such research. Grants from a state fund for stem-cell research are not affected, but federal research funds that flow to institutions such as the University of Maryland and the Johns Hopkins University would be cut off. That could affect a $500,000 experiment conducted by researchers in labs at both universities.
NEWS
By Gus G. Sentementes, The Baltimore Sun | October 5, 2012
Aging baby boomers are increasingly turning to testosterone prescriptions in a bid to stay healthy and boost their vitality. But the therapy has some health risks for men. Recently, scientists at the Johns Hopkins Bloomberg School of Public Health have been exploring how stem cells can be used to regenerate testosterone in aging men, without their having to resort to testosterone injections. "We're trying to understand whether you can prevent [diminishing testosterone], whether you can reverse that," said Dr. Barry Zirkin, a Hopkins researchers who has co-developed a new way to activate stem cells in the testes that, in turn, form the cells that produce testosterone.
HEALTH
By Kelly Brewington, The Baltimore Sun | April 23, 2010
With the financial backing of the Vatican, University of Maryland researchers will lead an international group of scientists to study adult stem cells from the intestines with the hope of discovering treatments for diseases while bypassing the ethical debates that have embroiled such research for a decade. The partnership, known as the International Intestinal Stem Cell Consortium, brings together researchers from the Center for Stem Cell Biology and Regenerative Medicine at the University of Maryland; the University of Salerno, Bambino Gesu — an Italian children's hospital; and the Istituto Superiore di Sanita — the Italian equivalent of the National Institutes of Health.
NEWS
By Jonathan Bor and Frank Roylance and Jonathan Bor and Frank Roylance,Sun reporters | November 21, 2007
Scientists in the U.S. and Japan have converted human skin cells into stem cells like the ones found in embryos, a breakthrough that could yield regenerative therapies without igniting the ethical debates that have embroiled the field for nearly a decade. Yesterday's announcements raise the possibility that cells taken from sick patients could be reprogrammed and used to repair tissues damaged by heart disease, diabetes and other illnesses. The technique, achieved earlier this year in mice, holds two potential advantages.
BUSINESS
By Michael Pollick | November 4, 1991
What's all the excitement about biotechnology? It is about being able to manipulate the cellular machinery of life to create products of value: pharmaceuticals and diagnostics.Until the mid-1970s, this cellular machinery, which works the same way for all living things, was really a black box. It didn't lend itself to manipulation.If you think of the human being as a computer, the extremely long molecule called DNA that is contained in every one of our cells is like the software system. It works like a hard disk on a computer, and it contains all the information that your body will ever use in its lifetime.